KRISTINE COLYER: Open Payments
NPI 1679064190 · MARION, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 40 payments from 12 companies in 2025. Trend: 2023 $351 · 2024 $545 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $196 |
| AstraZeneca Pharmaceuticals LP | 7 | $183 |
| PFIZER INC. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 4 | $30 |
| Lilly USA, LLC | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, QULIPTA, REXULTI, VOQUEZNA, MOUNJARO, INJECTAFER, Veozah.
Industry payments across IN — which companies pay providers there.
